

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of fibrinolysis (GO:0051917) | 8.85204600 |
| 2 | negative regulation of fibrinolysis (GO:0051918) | 8.68904607 |
| 3 | regulation of protein activation cascade (GO:2000257) | 8.11848938 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.81254592 |
| 5 | regulation of complement activation (GO:0030449) | 7.77479548 |
| 6 | complement activation, alternative pathway (GO:0006957) | 7.53249717 |
| 7 | ethanol oxidation (GO:0006069) | 7.46503727 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.46037801 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46037801 |
| 10 | omega-hydroxylase P450 pathway (GO:0097267) | 7.33368374 |
| 11 | exogenous drug catabolic process (GO:0042738) | 7.11370302 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.88160977 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.88160977 |
| 14 | protein carboxylation (GO:0018214) | 6.83121310 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.83121310 |
| 16 | drug catabolic process (GO:0042737) | 6.68366068 |
| 17 | blood coagulation, intrinsic pathway (GO:0007597) | 6.63313857 |
| 18 | glyoxylate metabolic process (GO:0046487) | 6.45910322 |
| 19 | fibrinolysis (GO:0042730) | 6.14752418 |
| 20 | ethanol metabolic process (GO:0006067) | 6.09129892 |
| 21 | cellular glucuronidation (GO:0052695) | 5.77988212 |
| 22 | imidazole-containing compound metabolic process (GO:0052803) | 5.70416277 |
| 23 | intestinal cholesterol absorption (GO:0030299) | 5.57931152 |
| 24 | regulation of plasminogen activation (GO:0010755) | 5.47201255 |
| 25 | uronic acid metabolic process (GO:0006063) | 5.45323366 |
| 26 | glucuronate metabolic process (GO:0019585) | 5.45323366 |
| 27 | urea metabolic process (GO:0019627) | 5.45234350 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 5.42246627 |
| 29 | negative regulation of protein activation cascade (GO:2000258) | 5.41211252 |
| 30 | negative regulation of sterol transport (GO:0032372) | 5.24557287 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 5.24557287 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.18123485 |
| 33 | drug metabolic process (GO:0017144) | 5.10738441 |
| 34 | protein activation cascade (GO:0072376) | 5.08997628 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.98807653 |
| 36 | cholesterol efflux (GO:0033344) | 4.97009253 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.90785645 |
| 38 | bile acid biosynthetic process (GO:0006699) | 4.85550702 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.83466499 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.83466499 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83466499 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.83165684 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.83165684 |
| 44 | regulation of apoptotic cell clearance (GO:2000425) | 4.77731240 |
| 45 | bile acid metabolic process (GO:0008206) | 4.73452447 |
| 46 | regulation of humoral immune response (GO:0002920) | 4.73108232 |
| 47 | glutamate metabolic process (GO:0006536) | 4.71566072 |
| 48 | complement activation, classical pathway (GO:0006958) | 4.65271117 |
| 49 | oxidative demethylation (GO:0070989) | 4.64742954 |
| 50 | urea cycle (GO:0000050) | 4.64009871 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 4.61723218 |
| 52 | high-density lipoprotein particle remodeling (GO:0034375) | 4.56424240 |
| 53 | negative regulation of complement activation (GO:0045916) | 4.55484502 |
| 54 | complement activation (GO:0006956) | 4.49519865 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 4.46037610 |
| 56 | plasma lipoprotein particle assembly (GO:0034377) | 4.43264242 |
| 57 | negative regulation of coagulation (GO:0050819) | 4.41174050 |
| 58 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.40152279 |
| 59 | glycine metabolic process (GO:0006544) | 4.37565632 |
| 60 | positive regulation of blood coagulation (GO:0030194) | 4.33320826 |
| 61 | positive regulation of hemostasis (GO:1900048) | 4.33320826 |
| 62 | negative regulation of wound healing (GO:0061045) | 4.30525966 |
| 63 | low-density lipoprotein particle remodeling (GO:0034374) | 4.28988773 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.26070654 |
| 65 | reverse cholesterol transport (GO:0043691) | 4.24919199 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.24649104 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.24649104 |
| 68 | acute-phase response (GO:0006953) | 4.17141278 |
| 69 | tyrosine metabolic process (GO:0006570) | 4.16450671 |
| 70 | phenylpropanoid metabolic process (GO:0009698) | 4.11178297 |
| 71 | plasma lipoprotein particle organization (GO:0071827) | 4.07608229 |
| 72 | positive regulation of coagulation (GO:0050820) | 3.98188352 |
| 73 | phospholipid efflux (GO:0033700) | 3.98121754 |
| 74 | regulation of triglyceride catabolic process (GO:0010896) | 3.97255260 |
| 75 | protein-lipid complex assembly (GO:0065005) | 3.93701565 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93435950 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93435950 |
| 78 | cytolysis (GO:0019835) | 3.86890739 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 3.85659438 |
| 80 | protein-lipid complex subunit organization (GO:0071825) | 3.82735011 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.80191103 |
| 82 | sodium-independent organic anion transport (GO:0043252) | 3.79110378 |
| 83 | amino-acid betaine metabolic process (GO:0006577) | 3.74749074 |
| 84 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.73359646 |
| 85 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.73359646 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69783336 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.63840456 |
| 88 | indole-containing compound catabolic process (GO:0042436) | 3.61098917 |
| 89 | indolalkylamine catabolic process (GO:0046218) | 3.61098917 |
| 90 | tryptophan catabolic process (GO:0006569) | 3.61098917 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.60530191 |
| 92 | aromatic amino acid family metabolic process (GO:0009072) | 3.55465105 |
| 93 | negative regulation of humoral immune response (GO:0002921) | 3.55220687 |
| 94 | negative regulation of lipase activity (GO:0060192) | 3.53499574 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.52584854 |
| 96 | drug transmembrane transport (GO:0006855) | 3.52198301 |
| 97 | intestinal absorption (GO:0050892) | 3.49582193 |
| 98 | arginine metabolic process (GO:0006525) | 3.49114078 |
| 99 | lipoprotein metabolic process (GO:0042157) | 3.44793855 |
| 100 | opsonization (GO:0008228) | 3.43097790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.87791979 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.23054137 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.78872782 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.73480462 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77440448 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.43056558 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90352411 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.65803324 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.52950888 |
| 10 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.39842354 |
| 11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.90086577 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.65505864 |
| 13 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.26582497 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.21185014 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2971889 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.80136790 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72402096 |
| 18 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.49198957 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47440042 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44581728 |
| 21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43060523 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39077447 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28781288 |
| 24 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28760332 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26990104 |
| 26 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25501298 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24198831 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23926067 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20254248 |
| 30 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18558383 |
| 31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16852389 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14052782 |
| 33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12620624 |
| 34 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07918603 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06572682 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06232025 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02582603 |
| 38 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02093473 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01120466 |
| 40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00826717 |
| 41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99118474 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97373736 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93290220 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92531441 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91211321 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90694576 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.90459297 |
| 48 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.88601219 |
| 49 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88358026 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87756158 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.87266977 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85437952 |
| 53 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85011924 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84388374 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83245357 |
| 56 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80692329 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78119201 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74374474 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72822361 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72364438 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.72351038 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71752382 |
| 63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71070080 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.70248529 |
| 65 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.70081372 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68794386 |
| 67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68725473 |
| 68 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67872918 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.67847676 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66116025 |
| 71 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.65500175 |
| 72 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.65451043 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63613877 |
| 74 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62606497 |
| 75 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.62284472 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61655058 |
| 77 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60577516 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.58371926 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.57988500 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57247040 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.56517058 |
| 82 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56343265 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.56289964 |
| 84 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55852490 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.55463177 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.55336648 |
| 87 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.54796385 |
| 88 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.54789239 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.53901424 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.53869881 |
| 91 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.52725570 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52696482 |
| 93 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.52651894 |
| 94 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.52422406 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.52305227 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.51345388 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50405558 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50345404 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.49821465 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.49821465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.03010376 |
| 2 | MP0005360_urolithiasis | 6.55996759 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.93240642 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.70931564 |
| 5 | MP0003195_calcinosis | 5.57306405 |
| 6 | MP0005365_abnormal_bile_salt | 5.54817980 |
| 7 | MP0003252_abnormal_bile_duct | 4.17278965 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.77217615 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.37440636 |
| 10 | MP0003868_abnormal_feces_composition | 3.29535246 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.08385792 |
| 12 | MP0009697_abnormal_copulation | 2.47358325 |
| 13 | MP0005332_abnormal_amino_acid | 2.19520874 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.03102819 |
| 15 | MP0000609_abnormal_liver_physiology | 1.93691591 |
| 16 | MP0003122_maternal_imprinting | 1.90961886 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.85375366 |
| 18 | MP0010368_abnormal_lymphatic_system | 1.84415953 |
| 19 | MP0005408_hypopigmentation | 1.81720003 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.75973538 |
| 21 | MP0002132_abnormal_respiratory_system | 1.70770402 |
| 22 | MP0009840_abnormal_foam_cell | 1.61880336 |
| 23 | MP0001661_extended_life_span | 1.58287216 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.47180832 |
| 25 | MP0001764_abnormal_homeostasis | 1.43611381 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.33035648 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.25534484 |
| 28 | MP0001915_intracranial_hemorrhage | 1.23948865 |
| 29 | MP0000598_abnormal_liver_morphology | 1.14081400 |
| 30 | MP0000566_synostosis | 1.07130921 |
| 31 | MP0005451_abnormal_body_composition | 1.05226885 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.04229975 |
| 33 | MP0009643_abnormal_urine_homeostasis | 0.95910468 |
| 34 | MP0002089_abnormal_postnatal_growth/wei | 0.94587983 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92396200 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.87429532 |
| 37 | MP0002282_abnormal_trachea_morphology | 0.86410680 |
| 38 | MP0005058_abnormal_lysosome_morphology | 0.84903000 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.83959764 |
| 40 | MP0005670_abnormal_white_adipose | 0.81194164 |
| 41 | MP0005464_abnormal_platelet_physiology | 0.77760012 |
| 42 | MP0000604_amyloidosis | 0.77143664 |
| 43 | MP0003172_abnormal_lysosome_physiology | 0.77004679 |
| 44 | MP0003011_delayed_dark_adaptation | 0.76048997 |
| 45 | MP0003123_paternal_imprinting | 0.74067253 |
| 46 | MP0009763_increased_sensitivity_to | 0.73373360 |
| 47 | MP0008469_abnormal_protein_level | 0.71336612 |
| 48 | MP0005395_other_phenotype | 0.70792314 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.70627861 |
| 50 | MP0002971_abnormal_brown_adipose | 0.69623325 |
| 51 | MP0008872_abnormal_physiological_respon | 0.68661045 |
| 52 | MP0003879_abnormal_hair_cell | 0.63554844 |
| 53 | MP0002168_other_aberrant_phenotype | 0.61396078 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.61007816 |
| 55 | MP0000639_abnormal_adrenal_gland | 0.59977072 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 0.57966025 |
| 57 | MP0004272_abnormal_basement_membrane | 0.50553679 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 0.49227058 |
| 59 | MP0005647_abnormal_sex_gland | 0.47781613 |
| 60 | MP0005448_abnormal_energy_balance | 0.47423078 |
| 61 | MP0003690_abnormal_glial_cell | 0.47308339 |
| 62 | MP0009053_abnormal_anal_canal | 0.46518881 |
| 63 | MP0003186_abnormal_redox_activity | 0.46049225 |
| 64 | MP0005187_abnormal_penis_morphology | 0.45749276 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.45728652 |
| 66 | MP0005535_abnormal_body_temperature | 0.44459806 |
| 67 | MP0004883_abnormal_blood_vessel | 0.43598231 |
| 68 | MP0005164_abnormal_response_to | 0.43358726 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.43111299 |
| 70 | MP0001756_abnormal_urination | 0.42837406 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.42407994 |
| 72 | MP0005023_abnormal_wound_healing | 0.41493027 |
| 73 | MP0003718_maternal_effect | 0.40811653 |
| 74 | MP0003953_abnormal_hormone_level | 0.40638443 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.40420862 |
| 76 | MP0003878_abnormal_ear_physiology | 0.40420862 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.39978393 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.39123963 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.38984199 |
| 80 | MP0005334_abnormal_fat_pad | 0.38477393 |
| 81 | MP0006054_spinal_hemorrhage | 0.38322008 |
| 82 | MP0009115_abnormal_fat_cell | 0.37675285 |
| 83 | MP0003567_abnormal_fetal_cardiomyocyte | 0.36710468 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.36040078 |
| 85 | MP0000249_abnormal_blood_vessel | 0.35919011 |
| 86 | MP0005409_darkened_coat_color | 0.35905884 |
| 87 | MP0004130_abnormal_muscle_cell | 0.35638803 |
| 88 | MP0009785_altered_susceptibility_to | 0.33612509 |
| 89 | MP0002933_joint_inflammation | 0.32658832 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.32247900 |
| 91 | MP0003941_abnormal_skin_development | 0.31818874 |
| 92 | MP0005266_abnormal_metabolism | 0.31623260 |
| 93 | MP0003632_abnormal_nervous_system | 0.31420680 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.30585792 |
| 95 | MP0003115_abnormal_respiratory_system | 0.29414460 |
| 96 | MP0000920_abnormal_myelination | 0.28706386 |
| 97 | MP0009764_decreased_sensitivity_to | 0.26833768 |
| 98 | MP0001324_abnormal_eye_pigmentation | 0.26772767 |
| 99 | MP0003699_abnormal_female_reproductive | 0.26193581 |
| 100 | MP0000371_diluted_coat_color | 0.25887200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.77776412 |
| 2 | Complement deficiency (HP:0004431) | 8.92083641 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.30045277 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.32563415 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.26760450 |
| 6 | Abnormality of complement system (HP:0005339) | 6.97673760 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 6.72766828 |
| 8 | Joint hemorrhage (HP:0005261) | 6.53845537 |
| 9 | Glomerulonephritis (HP:0000099) | 5.76569938 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.76213483 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 5.58253520 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.86178759 |
| 13 | Xanthomatosis (HP:0000991) | 4.81011784 |
| 14 | Spontaneous abortion (HP:0005268) | 4.46084168 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.44115473 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.31562723 |
| 17 | Hypercholesterolemia (HP:0003124) | 3.98113766 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96064973 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79187673 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.76888757 |
| 21 | Nephritis (HP:0000123) | 3.68218938 |
| 22 | Vascular calcification (HP:0004934) | 3.41544207 |
| 23 | Epidermoid cyst (HP:0200040) | 3.29844073 |
| 24 | Fat malabsorption (HP:0002630) | 3.26976656 |
| 25 | Menorrhagia (HP:0000132) | 3.22773591 |
| 26 | Hemorrhage of the eye (HP:0011885) | 3.20393373 |
| 27 | Mitral stenosis (HP:0001718) | 3.11958975 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.09099668 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07681334 |
| 30 | Gingival bleeding (HP:0000225) | 3.05913616 |
| 31 | Cardiovascular calcification (HP:0011915) | 2.99695204 |
| 32 | Hyperglycinemia (HP:0002154) | 2.91799839 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.87042070 |
| 34 | Osteomalacia (HP:0002749) | 2.84957183 |
| 35 | Fair hair (HP:0002286) | 2.81675414 |
| 36 | Purpura (HP:0000979) | 2.80857351 |
| 37 | Rickets (HP:0002748) | 2.76410000 |
| 38 | Hypophosphatemic rickets (HP:0004912) | 2.70365720 |
| 39 | Thrombophlebitis (HP:0004418) | 2.66307077 |
| 40 | Arthropathy (HP:0003040) | 2.62307470 |
| 41 | Hyperammonemia (HP:0001987) | 2.55786312 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 2.53318073 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.53318073 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.52622924 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.51775574 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.50960226 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.46953070 |
| 48 | Myocardial infarction (HP:0001658) | 2.36199343 |
| 49 | Acanthocytosis (HP:0001927) | 2.33159790 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.28211065 |
| 51 | Pulmonary embolism (HP:0002204) | 2.16579462 |
| 52 | Hyperglycinuria (HP:0003108) | 2.15123458 |
| 53 | Skin nodule (HP:0200036) | 2.07195644 |
| 54 | Poikilocytosis (HP:0004447) | 2.06524448 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.05666767 |
| 56 | Steatorrhea (HP:0002570) | 2.00264505 |
| 57 | Deep venous thrombosis (HP:0002625) | 11.3843613 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 1.99620322 |
| 59 | Cholecystitis (HP:0001082) | 1.99620322 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 1.98733055 |
| 61 | Increased serum pyruvate (HP:0003542) | 1.96885796 |
| 62 | Bifid scrotum (HP:0000048) | 1.92942760 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 1.91820501 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 1.90177012 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87069597 |
| 66 | Enlarged kidneys (HP:0000105) | 1.86777429 |
| 67 | Generalized hypopigmentation of hair (HP:0011358) | 1.86032466 |
| 68 | Hyperphosphaturia (HP:0003109) | 1.85785936 |
| 69 | Abnormality of carpal bone ossification (HP:0006257) | 1.83909736 |
| 70 | Blue irides (HP:0000635) | 1.82917652 |
| 71 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82114177 |
| 72 | Joint swelling (HP:0001386) | 1.77176521 |
| 73 | Ketosis (HP:0001946) | 1.77086566 |
| 74 | Cholelithiasis (HP:0001081) | 1.77024593 |
| 75 | Potter facies (HP:0002009) | 1.73479284 |
| 76 | Facial shape deformation (HP:0011334) | 1.73479284 |
| 77 | Abnormality of glycolysis (HP:0004366) | 1.73184987 |
| 78 | Epistaxis (HP:0000421) | 1.73119485 |
| 79 | Esophageal varix (HP:0002040) | 1.72912136 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 1.72663758 |
| 81 | Hydroxyprolinuria (HP:0003080) | 1.72663758 |
| 82 | Neonatal hypoglycemia (HP:0001998) | 1.72163242 |
| 83 | Hypoglycemic coma (HP:0001325) | 1.67838141 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.67755980 |
| 85 | Abnormal gallbladder morphology (HP:0012437) | 1.67191013 |
| 86 | Hypochromic anemia (HP:0001931) | 1.66722820 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 1.63033608 |
| 88 | Glycosuria (HP:0003076) | 1.63033608 |
| 89 | Elevated alkaline phosphatase (HP:0003155) | 1.62136897 |
| 90 | Broad alveolar ridges (HP:0000187) | 1.62085376 |
| 91 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.60971919 |
| 92 | Abnormal delivery (HP:0001787) | 1.59598926 |
| 93 | Abnormal urine phosphate concentration (HP:0012599) | 1.58985494 |
| 94 | Increased mean platelet volume (HP:0011877) | 1.57804628 |
| 95 | Abnormality of the nasal septum (HP:0000419) | 1.56730062 |
| 96 | Increased serum ferritin (HP:0003281) | 1.56567868 |
| 97 | Abnormality of vitamin metabolism (HP:0100508) | 1.55475396 |
| 98 | Metabolic acidosis (HP:0001942) | 1.53195744 |
| 99 | Gangrene (HP:0100758) | 1.52454392 |
| 100 | Peritonitis (HP:0002586) | 1.52274315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 6.95472389 |
| 2 | FGFR3 | 4.79366713 |
| 3 | BRSK2 | 3.22466008 |
| 4 | CDK12 | 3.22411939 |
| 5 | ICK | 3.15291183 |
| 6 | PIK3CA | 2.84776913 |
| 7 | WNK4 | 2.63095385 |
| 8 | ERN1 | 2.55211362 |
| 9 | PRKAA2 | 2.11399793 |
| 10 | FGFR2 | 2.05506696 |
| 11 | STK38L | 2.05467363 |
| 12 | EPHA2 | 2.03552233 |
| 13 | RIPK1 | 1.98977076 |
| 14 | AKT3 | 1.97551423 |
| 15 | SIK1 | 1.95348364 |
| 16 | FGFR1 | 1.93082375 |
| 17 | TYRO3 | 1.77995127 |
| 18 | TRIB3 | 1.56742193 |
| 19 | MAPK11 | 1.55951042 |
| 20 | PDGFRA | 1.50399545 |
| 21 | LATS1 | 1.48671250 |
| 22 | BRSK1 | 1.48445118 |
| 23 | TYK2 | 1.32033584 |
| 24 | SIK2 | 1.30208100 |
| 25 | PRKACG | 1.26570806 |
| 26 | CAMK1D | 1.26506448 |
| 27 | DYRK1B | 1.21668374 |
| 28 | TGFBR2 | 1.18687817 |
| 29 | MAP3K2 | 1.18162780 |
| 30 | EIF2AK1 | 1.17536585 |
| 31 | WNK1 | 1.15642621 |
| 32 | RET | 1.13924256 |
| 33 | PRKAA1 | 1.10718766 |
| 34 | NEK9 | 1.08934981 |
| 35 | ERBB2 | 1.07689406 |
| 36 | DDR2 | 1.01220484 |
| 37 | PDPK1 | 1.00496375 |
| 38 | MAP3K7 | 1.00315513 |
| 39 | STK24 | 1.00121340 |
| 40 | MST1R | 0.99202297 |
| 41 | IGF1R | 0.99000949 |
| 42 | SGK494 | 0.93031019 |
| 43 | SGK223 | 0.93031019 |
| 44 | NTRK3 | 0.91516420 |
| 45 | PKN2 | 0.85581295 |
| 46 | BCR | 0.84961026 |
| 47 | CSNK1E | 0.83279447 |
| 48 | LATS2 | 0.82810862 |
| 49 | SGK2 | 0.81234993 |
| 50 | STK39 | 0.79553761 |
| 51 | SGK3 | 0.76915048 |
| 52 | PRKCG | 0.73635327 |
| 53 | CDK7 | 0.72644522 |
| 54 | MAP3K3 | 0.72530921 |
| 55 | EPHA4 | 0.71945946 |
| 56 | RPS6KB1 | 0.71846971 |
| 57 | PDK1 | 0.71730726 |
| 58 | SGK1 | 0.70173693 |
| 59 | MAPKAPK3 | 0.68994412 |
| 60 | CAMK1G | 0.67693154 |
| 61 | CSF1R | 0.67492243 |
| 62 | WEE1 | 0.62962439 |
| 63 | MAP2K4 | 0.62918695 |
| 64 | PRKCZ | 0.60977457 |
| 65 | BCKDK | 0.59058939 |
| 66 | MAP3K5 | 0.58114086 |
| 67 | CSNK1D | 0.54449658 |
| 68 | MST4 | 0.53558475 |
| 69 | PRKG1 | 0.50876059 |
| 70 | CDK6 | 0.48247649 |
| 71 | FGR | 0.47867718 |
| 72 | PIK3CG | 0.47209544 |
| 73 | MTOR | 0.46970718 |
| 74 | CAMKK2 | 0.46087498 |
| 75 | FER | 0.44909551 |
| 76 | EPHA3 | 0.44848755 |
| 77 | BRD4 | 0.44637536 |
| 78 | JAK1 | 0.44624870 |
| 79 | NLK | 0.44280943 |
| 80 | CSNK2A1 | 0.42518740 |
| 81 | CSNK2A2 | 0.42464304 |
| 82 | SRC | 0.39755788 |
| 83 | PRKACA | 0.39530889 |
| 84 | CDC42BPA | 0.38780598 |
| 85 | RPS6KA3 | 0.37541977 |
| 86 | MAP2K3 | 0.36693832 |
| 87 | MAP3K12 | 0.36509311 |
| 88 | ERBB4 | 0.35753396 |
| 89 | MATK | 0.35645527 |
| 90 | IRAK3 | 0.34788536 |
| 91 | YES1 | 0.34283485 |
| 92 | FRK | 0.34210472 |
| 93 | MET | 0.33218879 |
| 94 | JAK2 | 0.32033537 |
| 95 | STK38 | 0.30458634 |
| 96 | CDK9 | 0.29263648 |
| 97 | PRKCB | 0.28346408 |
| 98 | PRKACB | 0.27271670 |
| 99 | SMG1 | 0.24099574 |
| 100 | EEF2K | 0.23996874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.41077991 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.89388675 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.88073293 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.81763553 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.39838099 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.38847837 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.35474486 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.94963329 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85893467 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.83702422 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.78297422 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.53816289 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49653811 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.46333659 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43935487 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.38095232 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.31557190 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.22543707 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.98987131 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.91412189 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82329907 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.81317084 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.69196978 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68885767 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53025081 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51088624 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49882273 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42941882 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39482891 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38743758 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37035079 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34554434 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.21248680 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12507863 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10254073 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08103701 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06936860 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04517499 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.04133458 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01818541 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99513771 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99472790 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98796058 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96799075 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96292883 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95730491 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.95661036 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90626839 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88310739 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85001011 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82212663 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81199729 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79842855 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75133284 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60693373 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60535450 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59075162 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.56372936 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54841046 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46743766 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40954137 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.39390548 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37046271 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35254022 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34894973 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.30325706 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26001770 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23247323 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23103179 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20398580 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20282608 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17262589 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14948640 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13768757 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11515074 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.09942078 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09903114 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09859109 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08427334 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.04373047 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.03655953 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03411197 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.03273491 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.00958948 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.2156057 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2124049 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2057764 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.2054248 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.2051016 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1882865 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1375203 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | -0.1301848 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0935970 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0913202 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0861920 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0859698 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0680437 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0470646 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0388752 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0316348 |

